Volume 17, Number 5—May 2011
Dispatch
Multitarget Test for Emerging Lyme Disease and Anaplasmosis in a Serosurvey of Dogs, Maine, USA
Table 1
Canine seroprevalence of Borrelia burgdorferi and Anaplasma phagocytophilum and Lyme diseases vaccination status, Maine, USA, 2007
County |
No. dogs tested |
B. burgdorferi* |
A. phagocytophilum* |
Lyme disease vaccination status |
|||||
No.
negative |
No. (%) positive |
No.
negative |
No. (%) positive |
No.
reporting |
No. (%) vaccinated |
||||
Aroostook | 59 | 56 | 3 (5.1) | 59 | 0 | 59 | 9 (15.3) | ||
Piscataquis | 46 | 44 | 2 (4.3) | 43 | 3 (6.5) | 44 | 23 (52.3) | ||
Somerset | 57 | 55 | 2 (3.5) | 54 | 3 (5.3) | 55 | 33 (60.0) | ||
Penobscot | 77 | 73 | 4 (5.2) | 73 | 4 (5.2) | 75 | 30 (40.0) | ||
Franklin | 78 | 73 | 5 (6.4) | 78 | 0 | 78 | 38 (48.7) | ||
Washington | 38 | 35 | 3 (7.9) | 37 | 1 (2.6) | 37 | 6 (16.2) | ||
Hancock | 54 | 46 | 8 (14.8) | 53 | 1 (1.9) | 54 | 24 (44.4) | ||
Oxford | 76 | 66 | 10 (13.2) | 75 | 1 (1.3) | 76 | 41 (53.9) | ||
Waldo | 62 | 57 | 5 (8.1) | 60 | 2 (3.2) | 62 | 38 (61.3) | ||
Kennebec | 120 | 106 | 14 (11.7) | 114 | 6 (5.0) | 119 | 82 (68.9) | ||
Knox | 87 | 67 | 20 (23.0) | 83 | 4 (4.6) | 81 | 44 (54.3) | ||
Lincoln | 91 | 75 | 16 (17.6) | 85 | 6 (6.6) | 85 | 63 (74.1) | ||
Androscoggin | 62 | 53 | 9 (14.5) | 60 | 2 (3.2) | 62 | 27 (43.5) | ||
Sagadahoc | 24 | 22 | 2 (8.3) | 23 | 1 (4.2) | 24 | 21 (87.5) | ||
Cumberland | 91 | 78 | 13 (14.3) | 72 | 19 (20.9) | 88 | 62 (70.5) | ||
York |
65 |
42 |
22 (34.4) |
41 |
24 (36.9) |
59 |
34 (57.6) |
||
Total | 1,087 | 948 | 138 (12.7) | 1,010 | 77 (7.1) | 1,058 | 575 (54.3) |
*Tested by using SNAP 4Dx test kit (IDEXX Laboratories, Westbrook, ME, USA).
Page created: August 08, 2011
Page updated: August 08, 2011
Page reviewed: August 08, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.